Cargando…
Usefulness of (18)F-Fluorodeoxyglucose Positron Emission Tomography for Follow-Up of 13-cis-Retinoic Acid Treatment for Residual Neuroblastoma After Myeloablative Chemotherapy
13-cis-retinoic acid (13-cis-RA) treatment is used as a second-line treatment for residual or recurrent neuroblastoma. However, determining the duration of 13-cis-RA treatment for residual and recurrent neuroblastoma can be a problem because it is difficult to evaluate the effectiveness of the treat...
Autores principales: | Sato, Yuya, Kurosawa, Hidemitsu, Sakamoto, Setsu, Kuwashima, Shigeko, Hashimoto, Teisuke, Okamoto, Kentaro, Tsuchioka, Takashi, Fukushima, Keitaro, Arisaka, Osamu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4616575/ https://www.ncbi.nlm.nih.gov/pubmed/26252303 http://dx.doi.org/10.1097/MD.0000000000001290 |
Ejemplares similares
-
Clear cell sarcoma of the kidney with calcification and a novel chromosomal abnormality: a case report
por: Kato, Masaya, et al.
Publicado: (2015) -
Central hypothyroidism in a pediatric case of primary acute monoblastic leukemia with central nervous system infiltration: A case report
por: Sato, Yuya, et al.
Publicado: (2017) -
Fluctuations in C-reactive protein in a hepatoblastoma patient with thrombocytosis
por: Sato, Yuya, et al.
Publicado: (2011) -
Burkitt-Type Acute Lymphoblastic Leukemia With Precursor B-Cell Immunophenotype and Partial Tetrasomy of 1q: A Case Report
por: Sato, Yuya, et al.
Publicado: (2016) -
Apatinib plus retinoic acid as maintenance for children with relapsed stage 4 high-risk neuroblastoma: Two case reports
por: Jin, Mei, et al.
Publicado: (2020)